Robuta

https://xentria.com/clinical/xtmab16-phase-1 XTMAB-16 Phase 1 - Xentria Xentria is developing XTMAB-16, a type of monoclonal antibody which aims to treat people with sarcoidosis. XTMAB-16 remains under development and the safety... phase